Skip to Late-Breaking Abstracts »

All accepted abstracts are available in the Journal for ImmunoTherapy of Cancer (JITC).

Abstract Titles

Poster Presentation Dates

All odd numbered posters will be presented on Wednesday, Nov. 11, from 5:15-5:45 p.m. EST and Friday, Nov. 13, from 4:40-5:10 p.m. EST. Even numbered posters will be presented on Thursday, Nov. 12, from 4:50-5:20 p.m. EST and Saturday, Nov. 14, from 1-1:30 p.m. EST.

Posters will be on display from 8 a.m. on Monday, Nov. 9, until the virtual poster hall closes on December 31, 2020.


Search word or phrase:

# Type Title Authors Category Keywords
475 Oral Presentation Incidental finding of colorectal cancer in a COVID-19 patient, followed by deep profiling of SARS-CoV-2-associated immune landscape and tumour microenvironment Chun Chau Lawrence Cheung, BA, MMedSc; Chun Chau Lawrence Cheung, BA, MMedSc; Xinru Lim; Denise Goh, BBiomedSc (Hons); Tracy Zhijun Tien; Jeffrey Chun Tatt Lim; Thuan Tong Tan; Shirin Kalimuddin; Jia Lin Ng; Jenny Guek-Hong Low; Joe P. Yeong, MD, PhD; Kiat Hon T. Lim; COVID and Immunotherapy COVID and Immunotherapy; Biomarkers; Chemokine; Cytokine; Immune contexture; Solid tumors; T cell; Tumor infiltrating lymphocytes (TILs); Tumor microenvironment
476 Poster Presentation AK119, a humanized anti-CD73 monoclonal antibody, as Immunotherapy for COVID-19 Tingting Zhong, MS; Zhaoliang Huang, BSc; Xinghua Pang, BSc; na chen, MD; Konyew Kwek, PhD; Chris Wynne, MB, ChB; Adam Konpa, MS; Xiaoping Jin, PhD; Yu Xia, PhD; Maxwell Zhongmin Wang, PhD; Baiyong Li, PhD; Yu Xia, PhD; COVID and Immunotherapy COVID and Immunotherapy; Antibody; B cell
477 Poster Presentation Deep Learning to Drive COVID-19 Rapid Drug Repurposing Sarah Kolitz, PhD; Jason Kim, PhD; Jenny Zhang, PhD; Yoonjeong Cha, PhD; Sailaja Battula, PhD; Rebecca Kusko, PhD; Rajaraman Krishnan, PhD; Benjamin J. Zeskind, PhD, MBA; Howard L. Kaufman, MD; COVID and Immunotherapy COVID and Immunotherapy; Bioinformatics; Systems biology
478 Poster Presentation Translation of a therapeutic neoantigen vaccine workflow to SARS-CoV-2 vaccine development Christof C. Smith, PhD; Christof C. Smith, PhD; Sarah Entwistle; Caryn Willis; Steven P. Vensko; Wolfgang Beck, AB; Jason Garness; Maria J. Sambade; Eric Routh; Kelly Olsen; Brandon Carpenter; Kaylee Gentry; Maria Fadri; Misha Fini; Amber Washington; Julia Kodysh, MSc; Timothy O'Donnell; Carsten Haber; Kirsten Heiss; Volker Stadler; Erik Garrison; Oliver C. Grant; Robert J. Woods; Mark Heise; Benjamin G. Vincent, MD; Alexander Rubinsteyn, PhD; COVID and Immunotherapy COVID and Immunotherapy; Antibody; B cell; Neoantigens; T cell; Vaccine
479 Poster Presentation A lymph-node targeted amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2 Martin Steinbuck, PhD; Peter C. DeMuth, PhD; Lochana Seenappa, MS; Christopher M. Haqq, MD, PhD; Aniela Jakubowski; Lisa K. McNeil, PhD; COVID and Immunotherapy COVID and Immunotherapy; Immune adjuvant; T cell; Vaccine
480 Oral Presentation Preliminary evaluation of a novel coronavirus vaccine (CORVax) using electroporation of plasmid DNA encoding a stabilized prefusion SARS-CoV-2 spike protein alone or with transfection of plasmid IL-12 Shawn M. Jensen, PhD; Christopher G. Twitty, PhD; Christopher C. Paustian, PhD; Madelein Laws; Glenna McDonnell, MS; Keith Wegmann; Tarsem L. Moudgil, MS; Michael E. Afentoulis, MSc; Mia Han; Kellie Malloy Foerter; David A. Canton, PhD; Jack Y. Lee; Bianca A. Nguyen; John Rodriguez; Kim Jaffe, PhD; Brian D. Piening, PhD; Carlo B. Bifulco, MD; Daniel J. O'Connor; Walter J. Urba, MD, PhD; Rom S. Leidner, MD; Traci L. Hilton, PhD; Hong-Ming Hu, PhD; Bernard A. Fox, PhD; COVID and Immunotherapy COVID and Immunotherapy; Antibody; B cell; Cytokine; Immune adjuvant; Immune monitoring; T cell; Vaccine
482 Poster Presentation COVID-19 in patients with lung cancer receiving immunotherapy. A report from an spanish academic center. David Viñal; Laura Gutierrez; Julia Villamayor; Oliver Higuera; Dario Sanchez Cabrero; Javier De Castro; COVID and Immunotherapy COVID and Immunotherapy; Clinical study; Solid tumors
483 Poster Presentation Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis Olivier OD. Demaria, PhD; Julien Carvelli, MD; Nassima Chouaki Benmansour, MD; Joanna Fares, PhD; Luciana Batista, PhD; Marie-Laure Thibult, PhD; Ariane Morel, PhD; Sabrina Carpentier, PhD; Romain Remark, PhD; Agnes Represa; Frederic Vely, PhD; Mikael Ebbo, MD; Nicolas Schleinitz, MD; Robert Zerbib, MSc; Yannis Morel, PhD; Eric Vivier, PhD; Olivier OD. Demaria, PhD; COVID and Immunotherapy COVID and Immunotherapy; Antibody; Biomarkers; Cytokine; Inflammation; MDSC; Monocyte/Macrophage; Myeloid cells